Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: Focus on functional, sensorimotor and biochemical changes

The Antioxidant Response as a Drug Target in Diabetic Neuropathy

(2008) Andrea Vincent et al.   CURRENT DRUG TARGETS

Role of Advanced Glycation End Products in Diabetic Neuropathy

(2008) Kazuhiro Sugimoto et al.   CURRENT PHARMACEUTICAL DESIGN

Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy

(2008) Manish Arora et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Long-Term Treatment With Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Suppresses Diabetic Neuropathy and Cataract Formation in Rats

(2008) Takafumi Matsumoto et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy

(2008) Shyam S. Sharma et al.   LIFE SCIENCES

Antinociceptive effect of resveratrol in carrageenan-evoked hyperalgesia in rats: Prolonged effect related to COX-2 expression impairment

(2008) Thi Aurore Pham-Marcou et al.   PAIN

PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy

(2007) Irina G. Obrosova et al.   FREE RADICAL BIOLOGY AND MEDICINE